Alnylam Pharmaceuticals Stock Forecast - Price Action Indicator
| ALNY Stock | USD 147.70 0.80 0.54% |
Alnylam Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Alnylam Pharmaceuticals stock prices and determine the direction of Alnylam Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Alnylam Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Alnylam Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Alnylam Pharmaceuticals' systematic risk associated with finding meaningful patterns of Alnylam Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of Alnylam Pharmaceuticals to cross-verify your projections. Alnylam |
Open Interest Against 2024-04-19 Alnylam Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Alnylam Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Alnylam Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Alnylam Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Alnylam Pharmaceuticals' open interest, investors have to compare it to Alnylam Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Alnylam Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Alnylam. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in Alnylam Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Alnylam Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Alnylam Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
Price Action indicator evaluates an asset for a given trading period using the following formula: ((close - open) + (close - high) + (close - low)) / 2. This indicator is consistent with the interpretation of Japanese candlestick patterns.| Previous Price Action Indicator | Price Action Indicator | Trend |
| (1.31) | (1.25) |
| Check Alnylam Pharmaceuticals Volatility | Backtest Alnylam Pharmaceuticals | Information Ratio |
Alnylam Pharmaceuticals Trading Date Momentum
| On April 16 2024 Alnylam Pharmaceuticals was traded for 147.70 at the closing time. The top price for the day was 150.37 and the lowest listed price was 146.73 . There was no trading activity during the period 0.0. Lack of trading volume on April 16, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.62% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Alnylam Pharmaceuticals to competition |
Other Forecasting Options for Alnylam Pharmaceuticals
For every potential investor in Alnylam, whether a beginner or expert, Alnylam Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Alnylam Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Alnylam. Basic forecasting techniques help filter out the noise by identifying Alnylam Pharmaceuticals' price trends.View Alnylam Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Alnylam Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Alnylam Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Alnylam Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Alnylam Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Alnylam Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alnylam Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Alnylam Pharmaceuticals stock market strength indicators, traders can identify Alnylam Pharmaceuticals entry and exit signals to maximize returns.
| Accumulation Distribution | 0.0242 | |||
| Daily Balance Of Power | (0.22) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 148.55 | |||
| Day Typical Price | 148.27 | |||
| Market Facilitation Index | 3.64 | |||
| Price Action Indicator | (1.25) | |||
| Period Momentum Indicator | (0.80) |
Alnylam Pharmaceuticals Risk Indicators
The analysis of Alnylam Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Alnylam Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting alnylam stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.47 | |||
| Standard Deviation | 2.16 | |||
| Variance | 4.67 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Alnylam Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alnylam Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Alnylam Stock
| 0.7 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
Moving against Alnylam Stock
| 0.93 | NVO | Novo Nordisk AS Financial Report 2nd of May 2024 | PairCorr |
| 0.77 | ABBV | AbbVie Inc Financial Report 25th of April 2024 | PairCorr |
| 0.75 | RZLT | Rezolute Trending | PairCorr |
| 0.7 | CELC | Celcuity LLC Financial Report 20th of May 2024 | PairCorr |
| 0.67 | HOWL | Werewolf Therapeutics Upward Rally | PairCorr |
The ability to find closely correlated positions to Alnylam Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alnylam Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alnylam Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alnylam Pharmaceuticals to buy it.
The correlation of Alnylam Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alnylam Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alnylam Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alnylam Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Alnylam Pharmaceuticals to cross-verify your projections. For more information on how to buy Alnylam Stock please use our How to Invest in Alnylam Pharmaceuticals guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Alnylam Stock analysis
When running Alnylam Pharmaceuticals' price analysis, check to measure Alnylam Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alnylam Pharmaceuticals is operating at the current time. Most of Alnylam Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alnylam Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alnylam Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alnylam Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Alnylam Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alnylam Pharmaceuticals. If investors know Alnylam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alnylam Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.52) | Revenue Per Share 14.637 | Quarterly Revenue Growth 0.312 | Return On Assets (0.05) | Return On Equity (15.01) |
The market value of Alnylam Pharmaceuticals is measured differently than its book value, which is the value of Alnylam that is recorded on the company's balance sheet. Investors also form their own opinion of Alnylam Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Alnylam Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alnylam Pharmaceuticals' market value can be influenced by many factors that don't directly affect Alnylam Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alnylam Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alnylam Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alnylam Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.